EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Immunotherapy as a treatment for Stroke: Utilizing regulatory T cells

Yuanwei Li, Devin W. McBride, Yingxin Tang, Desislava Doycheva, John H. Zhang, Zhouping Tang

Brain Hemorrhages · 2023-09 · 4 (3) · 147-153

DOI: 10.1016/j.hest.2023.02.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain Hemorrhages, 2023-09. Verfasst von Yuanwei Li und 5 weiteren Autor:innen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Hunan Province of China.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Stroke, a cerebrovascular disease with a high mortality rate, is categorized as either ischemic or hemorrhagic. Current existing therapies have limitations, including a narrow time window for treatment. As stroke induces a rapid and large immune response, immune cells and inflammatory mediators have become promising therapeutic targets for both ischemic and hemorrhagic strokes. In recent years, T cells have been investigated for their role in the pathogenesis of secondary injury and their therapeutic potential after stroke. And regulatory T cells, as one of the subpopulations of T cells, have been proved neuroprotective at both acute and recovery stages. In this review, we summarize the existing roles of Tregs in stroke and the various methods available for Treg intervention, and then provide a perspective for the future of immunotherapy in stroke.

Förderung

  • National Natural Science Foundation of China
  • Key Research and Development Program of Hunan Province of China

Zitieren

APA

Li, Y., McBride, D. W., Tang, Y., Doycheva, D., Zhang, J. H., & Tang, Z. (2023). Immunotherapy as a treatment for Stroke: Utilizing regulatory T cells. Brain Hemorrhages, 4(3), 147-153. https://doi.org/10.1016/j.hest.2023.02.003

Vancouver

Li Y, McBride DW, Tang Y, Doycheva D, Zhang JH, Tang Z. Immunotherapy as a treatment for Stroke: Utilizing regulatory T cells. Brain Hemorrhages. 2023;4(3):147-153. doi:10.1016/j.hest.2023.02.003

BibTeX
@article{Li2023,
  author = {Li, Yuanwei and McBride, Devin W. and Tang, Yingxin and Doycheva, Desislava and Zhang, John H. and Tang, Zhouping},
  title = {Immunotherapy as a treatment for Stroke: Utilizing regulatory T cells},
  journal = {Brain Hemorrhages},
  year = {2023},
  volume = {4},
  number = {3},
  pages = {147--153},
  doi = {10.1016/j.hest.2023.02.003}
}
Kostenlos starten →